Biosimilars

Biosimilars are safe and effective treatment options for many illnesses such as chronic skin and bowel diseases (like psoriasis, irritable bowel syndrome, Crohn’s disease and colitis), arthritis, kidney conditions, and cancer. Biosimilars increase access to lifesaving medications at potentially lower costs. Explore the website to learn more about biosimilars and to access all FDA’s educational resources for health care providers and patients.

Sub-Topic Paragraphs

Biosimilar Pages

Basics For Patients

Basics for Patients

Find useful information on biologics, including biosimilars

Overview for HCP

Overview for Health Care Professionals

Learn about biologics, including biosimilars and interchangeables

<a href=Review and Approval" width="420" height="220" />

Review and Approval

Review and approval for biosimilars and interchangeables

Biologic Innovation and Competition

Biological Product Innovation and Competition

Discover how FDA encourages biologic innovation and competition

Industry Resources

Industry Resources

Access industry resources on biologics, including biosimilars

Science and Research

Science and Research

FDA’s scientific research on biosimilars and interchangeables

Product Information and Education Resources

Product Information

Product Information

Information about FDA-approved biosimilar products

Curriculum Materials for <a href=Health Care Programs" width="420" height="220" />

Curriculum Materials for Health Care Programs

Explore our educational materials on biosimilars

Multimedia Education Materials

Multimedia Education Materials

Explore materials to help promote understanding of biosimilars